Carbon Biosciences Announces Four Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting May 3, 2024
Carbon Biosciences takes Aim at Cystic Fibrosis, Launching with $38M toward Next-Gen Gene Therapy June 27, 2022
Carbon Biosciences Emerges with a New Viral Vector to Shake up the Cystic Fibrosis Gene Therapy Field June 21, 2022
Carbon Biosciences Launches with $38 Million Series A Financing to Advance Novel Gene Therapy Platform and Pipeline June 21, 2022
